A piece of good news for young and middle-aged medical scientists around the globe! “Boyalife, Science & Science Translational Medicine Award in Stem Cells and Regenerative Medicine” has launched in Beijing this month.
Boyalife, Science and Science Translational Medicine Award in Stem Cells and Regenerative Medicine” is the first international medicine award jointly run by Chinese entrepreneur and Science, one of the most authoritative magazines in the world.
Bill Moran from Science and Professor Xu Xiaochun, President of Boyalife unveiled the award.
Professor Xu Xiaochun explains the objective for setting up the award:”It is for honoring and encouraging those young and middle aged scientists and researchers who have made outstanding contribution in the field of stem cell research and regenerative medicine around the globe. The award not only promotes the development in this field, but also strengthens the scientific communication between China and the rest of the world, speeds up the incubation of technological outcomes to serve the society. Plus, it is for expanding the global influence of Chinese entrepreneurs, ending the age of Made in China, but opening an era of Created in China.”
Bill Moran, the global director of Custom Publishing, International Collaboration, and Advertising for Science Publications evaluates the award positively. Science will establish a professional committee for the award with the magazine’s international impact.
“What we would like to do with Boyalife, is to give back to the scientific community by helping to support brilliant investigators. That’s why we came together to develop this prize. We hope with this prize, that it will identify young researchers and investigators who are striving to make curers and fast the curers particular in the area of stem cells and regenerative medicine. We are hoping to help them to continue to make those fast discoveries.”
Cao Xuetao, academician of China Engineering Academy, director of Chinese Academy of Medical Sciences places high expectations on the award’s setting up to increase China’s influence in the top medicine area.
“I just got off the plane from Stockholm, Sweden, where I witnessed Dr. Tu Youyou receiving the 2015 Nobel Prize in Physiology or Medicine. I was feeling so proud. This is the first Chinese Nobel laureate in physiology or medicine and the first citizen of the People’s Republic of China to receive the Nobel Prize in natural sciences. Her investigation has saved millions of lives. This is what medicine research means. I believe the setting up of the Boyalife and Science award will lead to more important investigations and breakthroughs in the stem cells and regenerative medicine.”
Stem cell and regenerative medicine is the new frontier in life sciences. The award recognizes significant contributions in advancing basic science to clinical applications in this field. It is focusing on developing cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation.
Science magazine was founded in 1880 with financial support from Thomas Edison. It is the academic journal of the American Association for the Advancement of Science and is one of the world’s top scientific journals.
Boyalife Group owns Boyalife stem cell bank, which is the biggest and the most automated stem cell bank in the world. It is the only clinical-grade stem cell bank accredited by both AABB standards that is standards for the American Association of Blood Banks, and certification of NRL, National Reference Laboratory set by WHO in China.